1,3-ditolylguanidine has been researched along with Nerve Degeneration in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Collier, LA; Hall, AA; Leonardo, CC; Pennypacker, KR; Rowe, DD; Willing, AE | 1 |
| Ajmo, CT; Collier, L; Cuevas, J; Pennypacker, KR; Vernon, DO | 1 |
2 other study(ies) available for 1,3-ditolylguanidine and Nerve Degeneration
| Article | Year |
|---|---|
Delayed treatments for stroke influence neuronal death in rat organotypic slice cultures subjected to oxygen glucose deprivation.
Topics: Animals; Brain; Brain Ischemia; Cell Hypoxia; Cord Blood Stem Cell Transplantation; Disease Models, Animal; Female; Glucose; Guanidines; Humans; In Vitro Techniques; Male; Microglia; Nerve Degeneration; Neurons; Nitric Oxide; Rats; Rats, Sprague-Dawley; Receptors, sigma; Stroke; Time Factors | 2009 |
Sigma receptor activation reduces infarct size at 24 hours after permanent middle cerebral artery occlusion in rats.
Topics: Animals; Anti-Inflammatory Agents; Anticonvulsants; Biomarkers; Brain; Brain Ischemia; Cell Survival; Disease Models, Animal; DNA-Binding Proteins; Encephalitis; Fluoresceins; Gliosis; Guanidines; Infarction, Middle Cerebral Artery; Male; Nerve Degeneration; Nerve Tissue Proteins; Neuroglia; Neuroprotective Agents; Nuclear Proteins; Organic Chemicals; Rats; Rats, Sprague-Dawley; Receptors, sigma; Time Factors; Treatment Outcome | 2006 |